Topics

Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials

12:15 EDT 12 Jun 2019 | Proactive Investors

The study looks at the effectiveness of ampligen in combination with the drug pembrolizumab at treating ovarian cancer

Original Article: Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials

NEXT ARTICLE

More From BioPortfolio on "Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...